01.05.2007 | Research Articles
Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients
Erschienen in: Clinical and Translational Oncology | Ausgabe 5/2007
Einloggen, um Zugang zu erhalten